2020-21 Melanoma

Scheme description
Molecular testing of Melanoma.
Disorders/Gene target(s)
Melanoma
BRAF
NRAS
KIT
Clinical cases
Five cases for round 1, Four cases for round 2
Testing/analysis
Any
Sample type
Formalin fixed paraffin embedded sections supplied as
1) rolled sections,
2) slide mounted sections
or 3) rolled sections plus one slide mounted section for H&E staining.
Please indicate your sample choice when enrolling.
Techniques
Any molecular testing methods.
Assessment
Submit a clinical report to include:
• Genotyping of results
• Interpretation of the result
• Clerical accuracy
Performance criteria are applied.
Eligibility
All laboratories worldwide
Languages
English ONLY
ISO1743 Accredited EQA
Yes
EQA timeline
Sample dispatchTBC
Testing period
Assessment results
Final Summary report
Other information
Two distributions per year
Fee
£675.00
GenQA code
2020MEL1
« Return to EQA scheme list
Go to top